Skip to main content
. Author manuscript; available in PMC: 2020 Nov 9.
Published in final edited form as: Lab Invest. 2018 Jan 18;98(5):620–628. doi: 10.1038/s41374-017-0013-4

Figure 2. Anti-CXCR3 treatment impedes the development of hyposalivation without affecting gross leukocyte infiltration of SMG in NOD mice.

Figure 2.

Anti-CXCR3 antibody or IgG was i.p.-administered to 4-week-old female NOD mice 3 times weekly for 6 weeks. (A) The volume of saliva that was collected during the 5 min period, normalized to body weight. (B) Images of H&E staining of SMG sections. Original magnification: ×200. Data are representative or the average of 6–12 mice for each group.